Drugs / Recombinant L-IFN adenovirus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05914935 | Jun 2023 → Jun 2024 | glioblastoma | Binhai Hospital of Fujian Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant L-IFN adenovirus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05914935 ↗ |
| Route | Other | “locally injected through the Ommaya reservoir” NCT05914935 ↗ |